Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study

Cadavid, Diego; Wolansky, Leo; Skurnick, Joan; A. Lincoln, John; Cheriyan, Jerry; Szczepanowski, Karolynn; Kamin, Stephen; R. Pachner, Andrew; Halper, June; D. Cook, S.

doi:10.1212/01.wnl.0000345970.73354.17

Public

Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study

Published in Neurology • Mar 11, 2009

Authors:

Diego Cadavid

Leo Wolansky

Joan Skurnick

Abstract

BACKGROUND: There are no published MRI studies comparing interferon beta 1b (IFNbeta-1b) and glatiramer acetate (GA) for treatment of relapsing multiple sclerosis (MS). OBJECTIVE: To compare the efficacy of IFNbeta-1b and GA for suppression of MS disease activity as evidenced on frequent brain MRI. ...

Subject

Glatiramer acetate

Multiple sclerosis

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!